Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CNSX:ATT NYSEARCA:IPO CVE:JTC NYSEARCA:PIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/AIPORenaissance IPO ETF$44.90+0.7%$43.73$31.20▼$48.23$145.93M1.2238,190 shs27,453 shsJTCJEMTECC$0.90-5.3%C$0.84C$0.65▼C$1.00C$2.51M0.384,488 shs500 shsPINInvesco India ETF$26.70-0.3%$26.57$23.07▼$31.17$233.89M0.7149,950 shs79,898 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%IPORenaissance IPO ETF+0.72%-0.62%+1.23%+24.01%+4.64%JTCJEMTEC0.00%0.00%+16.88%+4.65%+28.57%PINInvesco India ETF+0.60%-1.00%+0.87%+5.60%-10.79%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AN/AN/AIPORenaissance IPO ETFN/AN/AN/AN/AN/AN/AN/AN/AJTCJEMTECN/AN/AN/AN/AN/AN/AN/AN/APINInvesco India ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATTAbattis Bioceuticals 0.00N/AN/AN/AIPORenaissance IPO ETF 2.68Moderate Buy$44.910.02% UpsideJTCJEMTEC 0.00N/AN/AN/APINInvesco India ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AIPORenaissance IPO ETFN/AN/AN/AN/AN/AN/AJTCJEMTECC$1.59M1.58C$0.50 per share1.80C$0.84 per share1.07PINInvesco India ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATTAbattis BioceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/AIPORenaissance IPO ETFN/AN/A35.63∞N/AN/AN/AN/AN/AJTCJEMTECN/AC$0.0245.00∞N/A2.74%1.87%2.06%N/APINInvesco India ETFN/AN/A26.32∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATTAbattis BioceuticalsN/AN/AN/AN/AN/AIPORenaissance IPO ETF$0.160.36%N/AN/AN/AJTCJEMTECN/A7.14%N/AN/AN/APINInvesco India ETF$2.188.16%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATTAbattis BioceuticalsN/AN/AN/AIPORenaissance IPO ETFN/AN/AN/AJTCJEMTEC0.4011.9514.45PINInvesco India ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATTAbattis BioceuticalsN/AIPORenaissance IPO ETFN/AJTCJEMTECN/APINInvesco India ETF40.83%Insider OwnershipCompanyInsider OwnershipATTAbattis BioceuticalsN/AIPORenaissance IPO ETFN/AJTCJEMTEC50.14%PINInvesco India ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATTAbattis BioceuticalsN/AN/AN/ANot OptionableIPORenaissance IPO ETFN/A3.25 millionN/ANot OptionableJTCJEMTECN/A2.79 millionN/ANot OptionablePINInvesco India ETFN/A8.76 millionN/ANot OptionableIPO, JTC, PIN, and ATT HeadlinesRecent News About These CompaniesIndian Equities Are A Good Opportunity, But PIN Is Not The Best FundJuly 13, 2025 | seekingalpha.comPIN: 3 Reasons To Turn Cautiously Optimistic On This Quality Indian ETF (Rating Upgrade)July 10, 2025 | seekingalpha.comInvesco India ETFMay 24, 2025 | money.usnews.comShould You Buy the Dip in India ETFs Amid Pakistan Tensions?May 9, 2025 | zacks.comInvesco India ETF (PIN) Dividend HistoryApril 3, 2025 | nasdaq.comIndia ETFs Bounce Back: Here's WhyMarch 25, 2025 | zacks.comPIN: Quality Shines Through The Indian DownturnMarch 14, 2025 | seekingalpha.com(PIN) Trading SignalsJanuary 25, 2025 | news.stocktradersdaily.comN(PIN) Proactive StrategiesJanuary 14, 2025 | news.stocktradersdaily.comNInvesco India Short Term Fund Direct Daily Reinvestment of Income Dist cum Capital WtdrlJanuary 2, 2025 | businesstoday.inBPIN: Riding Out The Indian StormDecember 29, 2024 | seekingalpha.com(PIN) Long Term Investment AnalysisDecember 24, 2024 | news.stocktradersdaily.comNYear-ender 2024: Top 9 focused mutual funds deliver over 25% returns, Invesco India Focused Fund tops chartDecember 19, 2024 | msn.comLearn to Evaluate (PIN) using the ChartsDecember 1, 2024 | news.stocktradersdaily.comNHow the (PIN) price action is used to our AdvantageNovember 21, 2024 | news.stocktradersdaily.comNGondia Pin CodeNovember 7, 2024 | indiatvnews.comIAgripada Pin CodeNovember 6, 2024 | indiatvnews.comIIndia: 6 Insights For Emerging Markets Debt InvestorsNovember 5, 2024 | seekingalpha.comInvesco price target raised to $17.50 from $16.50 at Wells FargoOctober 24, 2024 | markets.businessinsider.comInvesco India Liquid Fund Direct Plan Monthly Payout of Income Dist cum Capital WtdrlOctober 18, 2024 | businesstoday.inBNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeChime’s Smart IPO: Half the Valuation, Double the StrengthBy Jeffrey Neal Johnson | June 18, 2025View Chime’s Smart IPO: Half the Valuation, Double the Strength3 Stocks Hitting All-Time Highs With More Room to RunBy Dan Schmidt | June 27, 2025View 3 Stocks Hitting All-Time Highs With More Room to RunNike Stock: The Mother of All Comebacks Might Have Just BegunBy Sam Quirke | June 27, 2025View Nike Stock: The Mother of All Comebacks Might Have Just BegunChipotle: Too Spicy for Smart Money to Resist After Stock SplitBy Jeffrey Neal Johnson | July 11, 2025View Chipotle: Too Spicy for Smart Money to Resist After Stock SplitIPO, JTC, PIN, and ATT Company DescriptionsAbattis Bioceuticals CNSX:ATTAbattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.Renaissance IPO ETF NYSEARCA:IPO$44.90 +0.33 (+0.74%) Closing price 03:59 PM EasternExtended Trading$44.76 -0.14 (-0.31%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Renaissance IPO ETF (IPO) is an exchange-traded fund that is based on the FTSE Renaissance IPO index. The fund tracks a market cap-weighted index of recent US-listed IPOs. The fund acquires issues within 90 days or sooner after IPO and sells after 3 years. IPO was launched on Oct 14, 2013 and is managed by Renaissance.JEMTEC CVE:JTCC$0.90 -0.05 (-5.26%) As of 07/14/2025 10:38 AM EasternJEMTEC Inc. provides integrated technology systems for community-based corrections in Canada. It offers services and technologies for offender monitoring in Canadian federal and provincial correctional departments. The company also provides various levels of technology, which allows corrections, courts, and police to select from various options ensuring the correct level of offender control. n addition, its offender location detection/verification technologies include offender reporting through telephone contact, offender reporting kiosks with integrated database, global positioning system active and passive tracking, voice verification, electronic monitoring house arrest systems, remote alcohol in-home monitoring, and private monitoring services. JEMTEC Inc. was incorporated in 1981 and is headquartered in North Vancouver, Canada.Invesco India ETF NYSEARCA:PIN$26.70 -0.08 (-0.30%) Closing price 03:59 PM EasternExtended Trading$26.73 +0.03 (+0.11%) As of 04:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PowerShares India Portfolio (the Fund) is based on the Indus India Index (Index). The Fund seeks to achieve its investment objective by investing substantially all of its assets in a wholly-owned subsidiary located in the Republic of Mauritius (the Subsidiary), which in turn invests at least 90% of its total assets in securities of Indian companies that consists of the Index, as well as American depositary receipts(ADR) and global depositary receipts (GDR) based on the securities in the Index. The Index is designed to represent the segment of the Indian equity markets. The Funds sectors allocations include consumers discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, materials and telecommunication services. Invesco PowerShares Capital Management LLC serves as investment adviser the Fund. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Citigroup Earnings Could Signal What’s Next for Markets This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
